Higenamine combined with [6]-gingerol suppresses doxorubicin-triggered oxidative stress and apoptosis in cardiomyocytes via upregulation of PI3K/Akt pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Yan Ling ^a,b   Zhuang, Xiao Dong ^c   Xu, Zhi Wei ^a   Lu, Li He ^a   Guo, Hua Lei ^a   Wu, Wei Kang ^a,b   Liao, Xin Xue ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(6) GINGEROL; 2 MORPHOLINO 8 PHENYLCHROMONE; CYTOCHROME C; DOXORUBICIN; HIGENAMINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RAZOXANE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84879382113     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/970490     Document Type: Article

References (47)

1. Das J., Ghosh J., Manna P., Sil P. C., Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochemical Pharmacology 2011 81 7 891 909 2-s2.0-79952575620 10.1016/j.bcp.2011.01.008
2. Brookins Danz E. D., Skramsted J., Henry N., Bennett J. A., Keller R. S., Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radical Biology and Medicine 2009 46 12 1589 1597 2-s2.0-67349234999 10.1016/j.freeradbiomed.2009.03.011
3. Kaiserová H., den Hartog G. J., Simůnek T., Schröterová L., Kvasnicková E., Bast A., Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin. British Journal of Pharmacology 2006 149 7 920 930
4. Zhang S., Liu X., Bawa-Khalfe T., Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nature Medicine 2012 18 11 1639 1642
5. Li K., Sung R. Y., Huang W. Z., Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Circulation 2006 113 18 2211 2220
6. Wu W., Su J., Lin S., Clinical study on therapeutic mechanism of Sini Decoction in treating post-percutaneous transluminal coronary angioplasty ischemia-reperfusion injury in terms of syndrome typing of TCM. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999 19 1 23 26 2-s2.0-0032889493
7. Jin M., Qin J., Wu W., Clinical study on "sini" decoction in treating stenocardia for coronary heart disease. Zhong Yao Cai 2003 26 1 71 73 2-s2.0-0642313919
8. Liang Y., Clinical study on "sini" decoction on treating stenocardia for coronary heart disease. Zhong Yao Cai 2005 28 8 737 739 2-s2.0-33748100858
9. Zhao M. Q., Wu W. K., Zhao D. Y., Duan X. F., Liu Y., Protective effects of sini decoction on adriamycin-induced heart failure and its mechanism. Zhong Yao Cai 2009 32 12 1860 1863 2-s2.0-79955942184
10. Zhao M. Q., Wu W. K., Zhao D. Y., Liu Y., Liu Y., Liang T. W., Luo H. C., Protective effects of Sini decoction on Adriamycin-induced heart failure and its mechanism: role of superoxide dismutase. Zhongguo Zhongyao Zazhi 2005 30 14 1111 1114 2-s2.0-33750911094
11. Ha Y. M., Kim M. Y., Park M. K., Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways. Apoptosis 2012 17 5 463 474
12. Pyo M. K., Kim J. M., Jin J. L., Chang K. C., Lee D. H., Yun-Choi H. S., Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregation. Thrombosis Research 2007 120 1 81 86 2-s2.0-34247157378 10.1016/j.thromres.2006.07.006
13. Park J. E., Kang Y. J., Park M. K., Lee Y. S., Kim H. J., Seo H. G., Lee J. H., Hye Sook Y. C., Shin J. S., Lee H. W., Ahn S. K., Chang K. C., Enantiomers of higenamine inhibit LPS-induced iNOS in a macrophage cell line and improve the survival of mice with experimental endotoxemia. International Immunopharmacology 2006 6 2 226 233 2-s2.0-30144437268 10.1016/j.intimp.2005.08. 007
14. Lee Y. S., Kang Y. J., Kim H. J., Park M. K., Seo H. G., Lee J. H., Yun-Choi H. S., Chang K. C., Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 2006 11 7 1091 1100 2-s2.0-33745826337 10.1007/s10495-006-7110-y
15. Kimura I., Makino M., Takamura Y., Islam M. A., Kimura M., Positive chronotropic and inotropic effects of higenamine and its enhancing action on the aconitine-induced tachyarrhythmia in isolated murine atria. Japanese Journal of Pharmacology 1994 66 1 75 80 2-s2.0-0028006669
16. Chrubasik S., Pittler M. H., Roufogalis B. D., Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005 12 9 684 701 2-s2.0-23844530273 10.1016/j.phymed.2004.07.009
17. Chakraborty D., Mukherjee A., Sikdar S., [6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxicology Letters 2012 210 1 34 43
18. Guh J. H., Ko F. N., Jong T. T., Teng C. M., Antiplatelet effect of gingerol isolated from Zingiber officinale. Journal of Pharmacy and Pharmacology 1995 47 4 329 332 2-s2.0-0028938125
19. Liao Y. R., Leu Y. L., Chan Y. Y., Kuo P. C., Wu T. S., Anti-platelet aggregation and vasorelaxing effects of the constituents of the rhizomes of Zingiber officinale. Molecules 2012 17 8 8928 8937
20. Zhai C. L., Zhang M. Q., Zhang Y., Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacologica Sinica 2012 33 12 1477 1487
21. Xu Z., Lin S., Wu W., Tan H., Wang Z., Cheng C., Lu L., Zhang X., Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF- B pathways and mitochondrial protective mechanisms. Toxicology 2008 247 2-3 133 138 2-s2.0-42749093343 10.1016/j.tox.2008.02.018
22. Zhang Q., Li Q., Chen Y., Homocysteine-impaired angiogenesis is associated with VEGF/VEGFR inhibition. Frontiers in Bioscience 2012 4 2525 2535
23. Dhar S., Lippard S. J., Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. Proceedings of the National Academy of Sciences of the United States of America 2009 106 52 22199 22204 2-s2.0-76049084604 10.1073/pnas.0912276106
24. Feng Y., Shi Z., Fang X., Xu M., Dai J., Perfluorononanoic acid induces apoptosis involving the Fas death receptor signaling pathway in rat testis. Toxicology Letters 2009 190 2 224 230 2-s2.0-69449084506 10.1016/j.toxlet.2009. 07.020
25. Hershko C., Link G., Tzahor M., Kaltwasser J. P., Athias P., Grynberg A., Pinson A., Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture. The Journal of Laboratory and Clinical Medicine 1993 122 3 245 251 2-s2.0-0027661677
26. Ek B., Hallberg C., Sjogren K. G., Hjalmarson A., Reoxygenation-induced cell damage of isolated neonatal rat ventricular myocytes can be reduced by chain-breaking antioxidants. Free Radical Biology and Medicine 1994 16 1 117 121 2-s2.0-0028121043 10.1016/0891-5849(94)90248-8
27. Wu W. K., Su J. W., Lin S. G., Clinical study on effect of sini decoction on ischemia/reperfusion injury by Holter monitoring in patients with acute myocardial infarction treated with thrombolytic therapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001 21 10 744 746 2-s2.0-0038814038
28. Wu W. K., Zhou L., Sun H. L., Experimental study on effect of sini decoction on myocardial endothelin in myocardial ischemic rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002 22 8 610 612 2-s2.0-0036706817
29. Zhao D. Y., Zhao M. Q., Wu W. K., Study on activity and mechanism of Sini Decoction anti-mitochondrial oxidation injury caused by myocardial ischemia/reperfusion. Zhong Yao Cai 2008 31 11 1681 1685 2-s2.0-70349758792
30. El-Bakly W. M., Louka M. L., El-Halawany A. M., Schaalan M. F., 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation. Cancer Chemotherapy and Pharmacology 2012 70 6 833 841
31. Liu L., Zhou H. Y., Ran K., Wang J. B., Glycyrrhiznatis ameliorates rabbit myocardial ischemia-reperfusion injury through P38MAPK pathway. Nan Fang Yi Ke Da Xue Xue Bao 2010 30 2 298 300
32. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D., The release of cytochrome c from mitochondria: a primary site for Bcl- 2 regulation of apoptosis. Science 1997 275 5303 1132 1136 2-s2.0-0031037897 10.1126/science.275.5303.1132
33. Kluza J., Marchetti P., Gallego M. A., Lancel S., Fournier C., Loyens A., Beauvillain J. C., Bailly C., Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 2004 23 42 7018 7030 2-s2.0-4844229364 10.1038/sj.onc.1207936
34. Taub M., Cutuli F., Activation of AMP kinase plays a role in the increased apoptosis in the renal proximal tubule in cystinosis. Biochemical and Biophysical Research Communications 2012 426 4 516 521
35. Kang Y. J., Chen Y., Epstein P. N., Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. Journal of Biological Chemistry 1996 271 21 12610 12616 2-s2.0-15844375301 10.1074/jbc.271.21.12610
36. Lyu Y. L., Kerrigan J. E., Lin C. P., Topoisomerase II β -mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Research 2007 67 18 8839 8846 2-s2.0-34548785032 10.1158/0008-5472.CAN-07-1649
37. Yan T., Deng S., Metzger A., Gödtel-Armbrust U., Porter A. C. G., Wojnowski L., Topoisomerase II α -dependent and -independent apoptotic effects of dexrazoxane and doxorubicin. Molecular Cancer Therapeutics 2009 8 5 1075 1085 2-s2.0-66849089422 10.1158/1535-7163.MCT-09-0139
38. Kalyanaraman B., Joseph J., Kalivendi S., Wang S., Konorev E., Kotamraju S., Doxorubicin-induced apoptosis: implications in cardiotoxicity. Molecular and Cellular Biochemistry 2002 234-235 119 124 2-s2.0-4243907381 10.1023/A:1015976430790
39. Liu L. L., Li Q. X., Xia L., Li J., Shao L., Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats. Toxicology 2007 231 1 81 90 2-s2.0-33846826959 10.1016/j.tox.2006.11.067
40. Hancock J. T., Desikan R., Neill S. J., Role of reactive oxygen species in cell signalling pathways. Biochemical Society Transactions 2001 29 2 345 350 2-s2.0-0034961888 10.1042/0300-5127:0290345
41. Gupta S., Molecular signaling in death receptor and mitochondrial pathways of apoptosis. International Journal of Oncology 2003 22 1 15 20 2-s2.0-0038177515
42. Tsang W. P., Chau S. P. Y., Kong S. K., Fung K. P., Kwok T. T., Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sciences 2003 73 16 2047 2058 2-s2.0-0042705073 10.1016/S0024-3205(03)00566-6
43. 2- and p53-dependent pathways. Journal of Biological Chemistry 2004 279 24 25535 25543 2-s2.0-2942616456 10.1074/jbc.M400944200
44. Marzo I., Brenner C., Zamzami N., Jürgensmeier J. M., Susin S. A., Vieira H. L. A., Prévost M. C., Xie Z., Matsuyama S., Reed J. C., Kroemer G., Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998 281 5385 2027 2031 2-s2.0-0032566649 10.1126/science.281.5385.2027
45. Chen Y., Jungsuwadee P., Vore M., Butterfield D. A., Clair D. K. S., Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Molecular Interventions 2007 7 3 147 156 2-s2.0-34347394526 10.1124/mi.7.3.6
46. Moungjaroen J., Nimmannit U., Callery P. S., Wang L., Azad N., Lipipun V., Chanvorachote P., Rojanasakul Y., Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. Journal of Pharmacology and Experimental Therapeutics 2006 319 3 1062 1069 2-s2.0-33751180574 10.1124/jpet.106.110965
47. Wang L., Zhou G. B., Liu P., Song J. H., Liang Y., Yan X. J., Xu F., Wang B. S., Mao J. H., Shen Z. X., Chen S. J., Chen Z., Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2008 105 12 4826 4831 2-s2.0-42449161986 10.1073/pnas.0712365105